Digestive cancer registry study
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects information from patients with different types of digestive cancers to better understand these diseases and improve future care. It does not test a new treatment, but helps doctors learn more about digestive cancers over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a diagnosis of one of these cancers: esophageal, stomach, pancreatic, liver, gallbladder or bile duct, small intestine, appendix, gastrointestinal stromal tumor (GIST), colorectal, anal canal, or a hereditary digestive cancer
- You must be willing to give written permission to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects health information and samples (a “cancer repository”) to help researchers study cancer and cancer risk. You may be able to join if you’ve had cancer before or if you’re at higher risk or have concerning findings.
This study collects medical information and tissue samples from people with gastrointestinal cancers (cancers of the stomach, colon, pancreas, or related organs). Researchers use this data to better understand these cancers and improve future treatments.
This study collects information from people diagnosed with pancreatic cancer. It aims to improve care by learning from your medical records.
This study builds a database for gallbladder cancer by collecting medical information and blood samples from patients. It helps doctors better understand the disease and improve future treatments.
This registry collects information from people with liver cancer or bile duct cancer to learn more about the disease and its treatment. Anyone 18 or older with any stage of these cancers can join.
This study builds a database of people with colorectal cancer. It may help doctors learn from real-world information to improve future care.
Hear when a new Bile Duct Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.